Related Experiment Video
Updated: Oct 17, 2025

In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages
Published on: February 14, 2021
PLCγ2 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages
Juliane Obst1, Hazel L Hall-Roberts2,3,4, Thomas B Smith2
1Alzheimer's Research UK Oxford Drug Discovery Institute, Centre for Medicines Discovery, University of Oxford, Oxford, UK. juliane.obst@cmd.ox.ac.uk.
Abstract:
Human genetic studies have linked rare coding variants in microglial genes, such as TREM2, and more recently PLCG2 to Alzheimer's disease (AD) pathology. The P522R variant in PLCG2 has been shown to confer protection for AD and to result in a subtle increase in enzymatic activity. PLCγ2 is a key component of intracellular signal transduction networks and induces Ca2+ signals downstream of many myeloid cell surface receptors, including TREM2. To explore the relationship between PLCγ2 and TREM2 and the role of PLCγ2 in regulating immune cell function, we generated human induced pluripotent stem cell (iPSC)- derived macrophages from isogenic lines with homozygous PLCG2 knockout (Ko). Stimulating TREM2 signalling using a polyclonal antibody revealed a complete lack of calcium flux and IP1 accumulation in PLCγ2 Ko cells, demonstrating a non-redundant role of PLCγ2 in calcium release downstream of TREM2. Loss of PLCγ2 led to broad changes in expression of several macrophage surface markers and phenotype, including reduced phagocytic activity and survival, while LPS-induced secretion of the inflammatory cytokines TNFα and IL-6 was unaffected. We identified additional deficits in PLCγ2- deficient cells that compromised cellular adhesion and migration. Thus, PLCγ2 is key in enabling divergent cellular functions and might be a promising target to increase beneficial microglial functions.
Insights
Phospholipase C gamma 2 (PLCγ2) is crucial for TREM2 signaling in brain immune cells, impacting Alzheimer's disease (AD) pathology. Its absence impairs microglial functions like calcium signaling and phagocytosis, suggesting PLCγ2 as a therapeutic target for AD.
Area of Science:
- Neuroimmunology
- Cellular Biology
- Biochemistry
Background:
- Genetic studies link microglial genes, including TREM2 and PLCG2, to Alzheimer's disease (AD) risk.
- A specific PLCG2 variant (P522R) is associated with AD protection and increased enzymatic activity.
- PLCγ2 mediates intracellular calcium (Ca2+) signals downstream of myeloid cell receptors like TREM2.
Purpose of the Study:
- To investigate the functional relationship between PLCγ2 and TREM2 signaling.
- To elucidate the role of PLCγ2 in regulating macrophage and microglial immune functions.
Main Methods:
- Generated isogenic human induced pluripotent stem cell (iPSC)-derived macrophages with homozygous PLCG2 knockout (Ko).
- Stimulated TREM2 signaling using a polyclonal antibody to assess calcium flux and inositol trisphosphate (IP1) accumulation.
- Analyzed macrophage surface marker expression, phagocytic activity, survival, cytokine secretion (TNFα, IL-6), adhesion, and migration.
Main Results:
- PLCγ2 knockout cells showed a complete absence of calcium flux and IP1 accumulation downstream of TREM2 stimulation, indicating a non-redundant role.
- Loss of PLCγ2 resulted in altered macrophage surface markers, reduced phagocytosis, and decreased cell survival.
- Deficiencies in cellular adhesion and migration were observed in PLCγ2-deficient cells.
- Lipopolysaccharide (LPS)-induced secretion of TNFα and IL-6 remained unaffected.
Conclusions:
- PLCγ2 is essential for TREM2-mediated calcium signaling and critical for diverse microglial functions, including phagocytosis, survival, adhesion, and migration.
- Targeting PLCγ2 may offer a strategy to enhance beneficial microglial functions in Alzheimer's disease.
More Related Videos
11:19Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
Published on: August 18, 2022
08:05Production and Characterization of Human Macrophages from Pluripotent Stem Cells
Published on: April 16, 2020